The Dollar Tree-Starboard Value situation leads to a bigger question: are activists the enemy or should they be treated like Wall Street runners with an urgent message?
Many U.S. manufacturers struggle to balance sustainability and the desire to make products at home with the need to reduce costs and boost their margins. Here's one that's succeeding.
While drug company CEOs are increasingly pilloried by activists following a series of price-hike scandals, at least two business leaders are advocating a pricing model they say could help restore the industry's credibility.
CEOs know the right pricing is critical to company performance. If you’re like most CEOs, you probably spend a lot to time discussing pricing with your team. Yet, time and again, CEOs and their teams get it wrong.
A recent survey shows that most companies are timid when it comes to price increases. But, by shifting policy to optimized pricing, companies can shift the battle to where their strengths lie -- in their ability to deliver unique benefits. All indications are that price optimization is invaluable, and helps prevent a brand from becoming a commodity.
CEOs are often the last defense against unrestrained discounting that degrades margins and destroys value.